Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | eukaryotic translation initiation factor 2 alpha | 0.0336 | 0.3872 | 0.3854 |
Onchocerca volvulus | 0.0286 | 0.326 | 1 | |
Brugia malayi | hypothetical protein | 0.0336 | 0.3872 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.2832 | 0.7316 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0057 | 0.0435 | 0.0408 |
Brugia malayi | Pre-SET motif family protein | 0.0036 | 0.0181 | 0.0195 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 1 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.0336 | 0.3872 | 0.5 |
Echinococcus granulosus | tumor protein p63 | 0.0408 | 0.4762 | 0.4747 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0336 | 0.3872 | 0.5 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0036 | 0.0181 | 0.0153 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0372 | 0.096 |
Onchocerca volvulus | 0.006 | 0.0473 | 0.0947 | |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0272 | 0.0244 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0.0181 | 0.5 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 0.4762 | 0.4747 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0036 | 0.0181 | 0.5 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0057 | 0.0435 | 0.0408 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.0625 | 0.0598 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.0625 | 0.0598 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.0073 | 0.0044 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0272 | 0.0244 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.0073 | 0.0044 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0336 | 0.3872 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0473 | 0.1221 |
Echinococcus multilocularis | eukaryotic translation initiation factor 2 alpha | 0.0336 | 0.3872 | 0.3854 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0044 | 0.0016 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0036 | 0.0181 | 0.0153 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.0789 | 0.2038 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0073 | 0.0044 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0035 | 0.0165 | 0.0137 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0057 | 0.0435 | 0.0408 |
Trypanosoma brucei | eukaryotic translation initiation factor 2-alpha kinase 1, putative | 0.0336 | 0.3872 | 0.5 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.0853 | 0.1979 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.0678 | 0.0652 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0181 | 0.0153 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0057 | 0.0435 | 0.0408 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.0307 | 0.0529 |
Leishmania major | protein kinase, putative | 0.0336 | 0.3872 | 0.5 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0025 | 0.0044 | 0.0114 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0308 | 0.0795 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.2832 | 0.7239 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0343 | 0.0886 |
Loa Loa (eye worm) | PEK/HRI protein kinase | 0.0336 | 0.3872 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.006 | 0.0473 | 0.0446 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0435 | 0.1123 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.326 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 5.0119 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | = 89.1251 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.